PW Medtech Group Limited (HKG:1358)
Hong Kong
· Delayed Price · Currency is HKD 1.120
-0.030 (-2.61%)
Apr 29, 2026, 4:08 PM HKT
PW Medtech Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 823.51 | 768.9 | 675.08 | 536.83 | 271.4 | Upgrade
|
| Revenue Growth (YoY) | 7.10% | 13.90% | 25.75% | 97.80% | 9.72% | Upgrade
|
| Cost of Revenue | 416.33 | 349.46 | 294.19 | 238 | 105.34 | Upgrade
|
| Gross Profit | 407.18 | 419.45 | 380.9 | 298.83 | 166.06 | Upgrade
|
| Selling, General & Admin | 268.86 | 240.88 | 195.11 | 189.57 | 123.09 | Upgrade
|
| Research & Development | 48.41 | 44.12 | 41.13 | 40.98 | 20.25 | Upgrade
|
| Other Operating Expenses | -30.67 | -39.55 | -34.48 | -29.89 | -24.35 | Upgrade
|
| Operating Expenses | 280.1 | 245.44 | 201.76 | 200.66 | 118.99 | Upgrade
|
| Operating Income | 127.08 | 174.01 | 179.14 | 98.17 | 47.07 | Upgrade
|
| Interest Expense | -0.72 | -0.37 | -0.15 | -0.46 | -0.61 | Upgrade
|
| Interest & Investment Income | 43.41 | 50.65 | 43.83 | 35.37 | 57.34 | Upgrade
|
| Currency Exchange Gain (Loss) | -6.88 | 7.5 | 3.49 | 30.47 | -40.88 | Upgrade
|
| EBT Excluding Unusual Items | 162.89 | 231.78 | 226.3 | 163.54 | 62.92 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -4.8 | -3.92 | Upgrade
|
| Gain (Loss) on Sale of Investments | 5.95 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.07 | -0.11 | -7.14 | -0.01 | 731.79 | Upgrade
|
| Asset Writedown | -3.04 | -1.18 | -0.06 | -0.25 | -52.59 | Upgrade
|
| Legal Settlements | -0.73 | -0.73 | -0.73 | -0.73 | -0.73 | Upgrade
|
| Other Unusual Items | - | - | 12.7 | - | - | Upgrade
|
| Pretax Income | 164.99 | 229.75 | 231.07 | 157.75 | 737.46 | Upgrade
|
| Income Tax Expense | 29.74 | 37.23 | 26.04 | 28.88 | -1.65 | Upgrade
|
| Earnings From Continuing Operations | 135.25 | 192.52 | 205.02 | 128.87 | 739.12 | Upgrade
|
| Net Income to Company | 135.25 | 192.52 | 205.02 | 128.87 | 739.12 | Upgrade
|
| Minority Interest in Earnings | -40.88 | -41.74 | -51.84 | -22.83 | 0 | Upgrade
|
| Net Income | 94.37 | 150.78 | 153.18 | 106.04 | 739.12 | Upgrade
|
| Net Income to Common | 94.37 | 150.78 | 153.18 | 106.04 | 739.12 | Upgrade
|
| Net Income Growth | -37.41% | -1.57% | 44.46% | -85.65% | 16.98% | Upgrade
|
| Shares Outstanding (Basic) | 1,511 | 1,543 | 1,566 | 1,566 | 1,569 | Upgrade
|
| Shares Outstanding (Diluted) | 1,511 | 1,543 | 1,566 | 1,566 | 1,569 | Upgrade
|
| Shares Change (YoY) | -2.11% | -1.42% | -0.03% | -0.20% | -0.00% | Upgrade
|
| EPS (Basic) | 0.06 | 0.10 | 0.10 | 0.07 | 0.47 | Upgrade
|
| EPS (Diluted) | 0.06 | 0.10 | 0.10 | 0.07 | 0.47 | Upgrade
|
| EPS Growth | -36.06% | -0.11% | 44.46% | -85.63% | 16.99% | Upgrade
|
| Free Cash Flow | - | 261.93 | 163.73 | 216.77 | 25.92 | Upgrade
|
| Free Cash Flow Per Share | - | 0.17 | 0.10 | 0.14 | 0.02 | Upgrade
|
| Dividend Per Share | 0.058 | 0.092 | 0.089 | - | - | Upgrade
|
| Dividend Growth | -37.55% | 3.00% | - | - | - | Upgrade
|
| Gross Margin | 49.44% | 54.55% | 56.42% | 55.66% | 61.19% | Upgrade
|
| Operating Margin | 15.43% | 22.63% | 26.54% | 18.29% | 17.34% | Upgrade
|
| Profit Margin | 11.46% | 19.61% | 22.69% | 19.75% | 272.34% | Upgrade
|
| Free Cash Flow Margin | - | 34.06% | 24.25% | 40.38% | 9.55% | Upgrade
|
| EBITDA | 242.36 | 289.28 | 276.11 | 175.49 | 77.98 | Upgrade
|
| EBITDA Margin | 29.43% | 37.62% | 40.90% | 32.69% | 28.73% | Upgrade
|
| D&A For EBITDA | 115.28 | 115.28 | 96.97 | 77.32 | 30.91 | Upgrade
|
| EBIT | 127.08 | 174.01 | 179.14 | 98.17 | 47.07 | Upgrade
|
| EBIT Margin | 15.43% | 22.63% | 26.54% | 18.29% | 17.34% | Upgrade
|
| Effective Tax Rate | 18.03% | 16.20% | 11.27% | 18.31% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.